Envue Medical Inc.
13F holders, Q1 2026 (March 31)13holders +7
8new positions
3sold out
$2.26avg. 13F price*
At the end of Q1 2026, 13 institutions reported holding Envue Medical Inc. in their 13F filings, up 7 from Q4 2025. 8 opened new positions and 3 sold out. The largest holders were Geode Capital Management, LLC ($53K), Schonfeld Strategic Advisors LLC ($32K) and Morgan Stanley ($24K).
- Company
- Envue Medical Inc.
- CUSIP
- 63008J884
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $172K |
| Exits | 3 | $38K |
All 13F filers, Q4 2025 → Q1 2026: 77,345 shares bought and 16,561 shares sold, net +60,784 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Geode Capital Management, LLC | 0.00% | New | 22,417 | $53K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 13,545 | $32K |
| Morgan Stanley | 0.00% | New | 10,000 | $24K |
| Osaic Holdings, Inc. | 0.00% | New | 10,000 | $24K |
| International Assets Investment Management, LLC | 0.00% | New | 10,000 | $21K |
| Poehling Capital Management, INC. | 0.00% | New | 10,000 | $17K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +56.2% | 2,819 | $7K |
| FMR LLC | 0.00% | New | 324 | $771 |
| Vanguard Capital Management LLC | 0.00% | — | 189 | $450 |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 85 | $202 |
| Wells Fargo & Company | 0.00% | New | 45 | $107 |
| UBS Group AG | 0.00% | Reduce -60.0% | 24 | $57 |
| SBI Securities Co., Ltd. | 0.00% | No change | 15 | $36 |
"% of holder's portfolio" is ENVUE MEDICAL INC.'s weight in each manager's 13F, not the share of Envue Medical Inc. the manager owns.